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VETERINARY MICROBIOLOGY
Establishing Streptomycin Epidemiological Cut-Off
Values for Salmonella and Escherichia coli
Lourdes Garcia-Migura,1,{ Marianne Sunde,2 Susanne Karlsmose,1 Kees Veldman,3 Andreas Schroeter,4
Beatriz Guerra,4 Sophie A. Granier,5 Agne`s Perrin-Guyomard,6 Mireille Gicquel-Bruneau,6 Alessia Franco,7
Stina Englund,8 Christopher Teale,9 Helmi Heiska,10 Lurdes Clemente,11 Patrick Boerlin,12 Miguel A. Moreno,13
Danielle Daignault,14 Dik Mevius,3 Rene S. Hendriksen,1 and Frank M. Aarestrup1
This study was conducted to elucidate the accuracy of the current streptomycin epidemiological cut-off value
(ECOFF) for Escherichia coli and Salmonella spp. A total of 236 Salmonella enterica and 208 E. coli isolates exhibiting
MICs between 4 and 32mg/L were selected from 12 countries. Isolates were investigated by polymerase chain
reaction for aadA, strA, and strB streptomycin resistance genes. Out of 236 Salmonella isolates, 32 (13.5%) yielded
amplicons for aadA (n¼ 23), strA (n¼ 9), and strB (n¼ 11). None of the 60 Salmonella isolates exhibiting MIC
4mg/L harbored resistance genes. Of the Salmonella isolates exhibiting MICs 8mg/L, 16mg/L, and 32mg/L,
1.6%, 15%, and 39%, respectively, tested positive for one or more genes. For most monitoring programs, the
streptomycin ECOFF for Salmonella is wild type (WT) 32 or 16mg/L. A cut-off value of WT 32mg/L would
have misclassified 13.5% of the strains as belonging to the WT population, since this proportion of strains
harbored resistance genes and exhibited MICs 32mg/L. Out of 208 E. coli strains, 80 (38.5%) tested positive for
aadA (n¼ 69), strA (n¼ 18), and strB (n¼ 31). Of the E. coli isolates exhibiting MICs of 4mg/L, 8mg/L, 16mg/L,
and 32mg/L, 3.6%, 17.6%, 53%, and 82.3%, respectively, harbored any of the three genes. Based on the European
Committee on Antimicrobial Susceptibility Testing guidelines (ECOFF 16mg/L), 25% of the E. coli strains
presenting MIC 16mg/L would have been incorrectly categorized as belonging to the WT population.
The authors recommend an ECOFF value of WT 16mg/L for Salmonella and WT 8mg/L for E. coli.
Introduction
S treptomycin is an aminoglycoside antimicrobial, andwas one of the first antimicrobial agents to be discovered
in the early 1940s.16 The binding of streptomycin to the 16S
ribosomal RNA leads to inhibition of protein synthesis3 and
has a bactericidal effect in the bacterium.
Several mechanisms of resistance have been described in
bacterial species belonging to the family Enterobacteriaceae.
These are mainly attributed to aminoglycoside-modifying
enzymes.23 The most common genes associated with
streptomycin resistance are the phosphotransferase genes
encoded by strA and strB.13,14,19 In addition, the aadA gene
encode for an aminoglycoside adenylyltransferase that in-
activate streptomycin and spectinomycin.15 aadA genes are
widely disseminated among Enterobacteriaceae and gener-
ally located on gene cassettes integrated into integrons.6
Mutations in the rpsL gene encoding the ribosomal protein
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S12 are also known to confer resistance to streptomy-
cin.7,22,24
In general, streptomycin is used as an epidemiological
marker in monitoring programs for antimicrobial resistance
in Salmonella and Escherichia coli. In particular, streptomycin
resistance in Salmonella is used as an indicator for the pres-
ence of the pentaresistance phenotype, exhibiting resistance
to ampicillin, chloramphenicol, streptomycin, sulphona-
mides, and tetracyclines associated with Salmonella enterica
serovar Typhimurium phage type DT104.1
Several proficiency tests involving antimicrobial suscepti-
bility testing have consistently reported discrepancies in the
interpretation of results obtained when performing these tests
against streptomycin for E. coli and Salmonella.9,10,12 These dif-
ferences might be the consequence of the epidemiological cut-
off values (ECOFF)/breakpoints used for categorizing the
strains as wild type (WT)/non-WT. The purpose of ECOFF
values is to separate theWT (microorganismswithout acquired
resistance mechanisms) and non-WT population, which is de-
fined as microorganisms with acquired resistance mechanisms
to an agent.18 According to data collected by the European
Committee on Antimicrobial Susceptibility Testing (EUCAST,
www.eucast.org), the recommended ECOFF value for strepto-
mycin is WT 16mg/L for both Salmonella and E. coli (data
from the EUCAST MIC distribution Web site, last accessed 8
March, 2011). The Clinical and Laboratory Standards Institute
has not defined clinical breakpoints for interpretation of mini-
mum inhibitory concentrations (MIC) for streptomycin. As a
result, some monitoring programs such as the National Anti-
microbial Resistance Monitoring System (www.cdc.gov/
narms/) and the Canadian Integrated Program for Anti-
microbial Resistance Surveillance (www.phac-aspc.gc.ca/
cipars-picra/analys-eng.php) have set their ECOFF values for
interpretation at 32mg/L for both organisms.
In a study carried out by Sunde and Norstrom,21 136 E. coli
strains with MICs 16mg/L collected from the Norwegian
monitoring program for antimicrobial resistance in bacteria
from feed, food, and animals (NORM-VET, www.vetinst.no/
eng) were investigated. Streptomycin resistance genes were
detected in 65% of the strains with MIC ¼16mg/L. Based on
the results, it was proposed that WT 8mg/L was as a better
cut-off value for streptomycin. A similar study performed by
Doran et al. in Salmonella Typhimurium concluded that inter-
pretive criteria for streptomycin MIC results should be sus-
ceptible at 8mg/L and resistant at >16mg/L.5
The purpose of this study was to establish the most opti-
mal ECOFF MIC values for streptomycin with respect to
E. coli and Salmonella and correlate the presence/absence of
streptomycin resistance genes with MICs. We have investi-
gated the presence of the most common streptomycin resis-
tance genes described in Enterobacteriaceae (aadA, strA, and
strB) in a total of 444 isolates (236 Salmonella and 208 E. coli)
exhibiting MIC values ranging between 4 and 32mg/L. To
minimize any possible bias due to geographical clustering of
resistance genes or phenotypic trends, the isolates were col-
lected from 12 different countries.
Materials and Methods
Selection of isolates
The European Union Reference Laboratory for Anti-
microbial Resistance (EURL-AR) circulated a project pro-
posal to the 27 veterinary and food safety institutes within
the network of national reference laboratories for antimi-
crobial resistance appointed by the European Union. In ad-
dition, the Public Health Agency of Canada, Centers for
Disease Control and Prevention in the United States, and the
Institute for Infectious Disease Control and Prevention in
China (Henan province) were invited to participate. Partici-
pating institutions were requested to select a maximum of
20 Salmonella and 20 E. coli isolates from their respective
national collections. For both genera, every institute was
asked to randomly select five isolates from routine moni-
toring with the following streptomycin MIC values: 4, 8, 16,
and 32mg/L. A total of 12 institutes situated in Germany,
Denmark, Norway, Sweden, Spain, Portugal, the Netherlands,
France, Italy, Finland, the United Kingdom, and Canada ac-
cepted the invitation. The United Kingdom participated in the
Salmonella study only. Portugal obtained only one E. coli iso-
late for each of the following streptomycin MIC values: 8, 16,
and 32mg/L, respectively, and only two Salmonella isolates
exhibiting MIC 32mg/L. France tested four instead of five
Salmonella isolates exhibiting MIC 32mg/L. As a result, a total
of 208 E. coli and 236 Salmonella isolates were included in the
study.
In addition, each country provided information on the
streptomycin MIC distribution for both genera during 2007
or 2008. Countries lacking these data provided the distribu-
tion of the populations for periods they had available. MIC
distributions reported by Canada were excluded from the
analysis since they only reported the number of isolates with
MIC 32, 64, and >64mg/L.
Quality control of MIC results obtained
by participating institutions
Invitation is annually announced through the EURL-AR
network to all national reference laboratories in antimicrobial
resistance to participate in a self-evaluating proficiency tests
(EQAS external quality assurance system) for antimicrobial
susceptibility testing in E. coli and Salmonella. These trials are
conducted each year to test if the current methodologies are
accurate, adequate, and reliable. The goal is to have all lab-
oratories performing antimicrobial susceptibility testing with
a maximum of 5% deviations. Eight strains of each species
(E. coli and Salmonella) are selected for each EQAS iteration.
Participating laboratories are instructed to perform the sus-
ceptibility testing method that is routinely used by their
laboratory. After completion of the susceptibility testing of
the test strains and the quality control strains, the partici-
pating laboratories are instructed to record the obtained re-
sults, using MIC values or zone-diameter in millimeters, and
categorize each of the tested strains as either resistant (R) or
susceptible (S) against each tested antimicrobial agent ap-
plying the EUCAST ECOFF values. After submitting the data
to the secured Web site, the laboratories obtain an instantly
generated individual report evaluating the submitted results
where all deviations from the expected interpretations are
reported. For the quality control strains, deviations are de-
fined as values that exceed the quality control range of the
strain. For both genera Salmonella and E. coli, during the
EQAS 2008 and 2009, the overall performance range between
98% and 98.3% correctly categorized isolates, respectively.
All laboratories participating in this study routinely per-
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formed MIC methods (Sensititre, Trek Diagnostic Systems,
Magallan Bioscience or VetMIC, SVA, Sweden) with the
exception of two laboratories that used the agar dilution
method and disk diffusion, respectively. In addition, when
evaluating the results obtained testing the EQAS strains
against streptomycin in the EQAS 2010, only two laborato-
ries failed to obtain the expected MIC value in only one
strain of the eight evaluated; these MIC values deviated with
a one-step dilution from the expected result. Further, labo-
ratories participating in this study produced between 98%
and 100% of correct results. With similar percentage of cor-
rect results, the Public Health Agency of Canada has par-
ticipated in the World Health Organization (WHO) EQAS for
Salmonella. The WHO EQAS proficiency test is also carried
out annually in the same terms as the one described above.10
Detection of streptomycin resistance genes
All isolates were examined by polymerase chain reaction
(PCR) for the presence of the following genes: aadA (aadA1
and aadA2), strA, and strB. All institutes were requested to
follow the same published protocols2,8,17 when they exam-
ined their own isolates by PCR. Positive control strains
(Salmonella Rissen 0112F31302F and Salmonella Typhimurium
P502212 DT104) were provided by the EURL-AR to all par-
ticipating laboratories. Obtained results were forwarded to
the National Food Institute in Denmark for further analysis.
Results
The strA, strB, and/or aadA genes were detected in 32
(13.5%) Salmonella strains out of the 236 strains investigated.
Some of the Salmonella strains harbored more than one re-
sistance gene, exhibiting different combinations of the resis-
tance genes investigated (Table 1). None of the 60 Salmonella
strains exhibiting MIC of 4mg/L contained any of the re-
sistance genes tested. Out of 60 Salmonella strains exhibiting
MIC values of 8 and 16mg/L, one (1.6%) and nine (15%),
respectively, yielded amplicons for any of the three genes
analyzed. In total, 5.5% of these isolates that harbored the
resistance genes with MIC 4, 8, and 16mg/L would be
classified as WT population if the ECOFF value is set at WT
16mg/L. In addition, 22 (39%) out of 56 strains exhibiting
MIC of 32mg/L tested positive for one or more of the
streptomycin resistance genes. This 39% of the strains would
be classified as WT if a cut-off value of WT 32mg/L is
used. Of the 32 Salmonella strains positive by PCR, 23 carried
aadA genes, 11 harbored strB, and 9 strA.
For E. coli, the proportion of strains harboring resistance
determinants was significantly higher (w2, p< 0.001) than
that for Salmonella. Three (3.6%) and nine (17.6%) of the E. coli
strains with MIC values of 4 and 8mg/L, respectively, har-
bored resistance genes (Table 2). A cut-off value of WT
8mg/L would cause the classification of 11.3% of the
strains harboring resistance genes as WT population. In
addition, 27 (53%) and 43 (82.3%) of the strains with MIC
values of 16 and 32mg/L, respectively, tested positive for
the presence of one or more of the genes. Setting a cut-off
value of WT 16mg/L would classified 53% of the strains
with MIC 16mg/L containing resistance genes as WT pop-
ulation. In total, the strA, strB, and aadA genes were detected
in 80 (38.5%) of the 208 E. coli strains investigated. The
number of strains harboring the aadA, strB, and strA resis-
tance genes was 69, 31, and 18, respectively. Further, some
E. coli strains presented different combinations of the resis-
tance genes (Table 2).
Figure 1 shows the streptomycin MIC distribution for
Salmonella and E. coli collected from 11 and 10 different
countries, respectively. The Salmonella distribution was
based on a total of 9,191 observations and the E. coli was
based on 5,171.
Discussion
For most monitoring programs (www.eurl-ar.eu/206-
monitoring_reports.htm#can), the streptomycin ECOFF
value for both S. enterica and E. coli is WT 16mg/L or WT
32mg/L. Results from this investigation showed that a low
proportion of the Salmonella strains presenting MIC values
16mg/L tested positive for one or more of the three
resistance genes. A cut-off value of WT 32mg/L would
have resulted in misclassification of 39% of the strains
with MIC 32mg/L, as these strains contained streptomycin
resistance genes but would have been categorized as be-
longing to the WT population. In addition and based on
the guidelines recommended by EUCAST, 53% of the E. coli
strains with an MIC of 16mg/L would have been classified
Table 1. Streptomycin Resistance Genes in Salmonella
Strains with Minimum Inhibitory Concentration
Values Ranging From 4 to 32 mg/L
MIC (mg/L)
Genes 4 8 16 32
aadA 0 0 5 14
strB 0 0 1 2
strA 0 0 1 0
strAþstrB 0 1 1 3
aadAþstrA 0 0 0 1
aadAþstrAþstrB 0 0 1 2
None 60 59 51 34
Number of strains 60 60 60 56
The gray color represents MIC values above the ECOFF value
suggested by the authors.
ECOFF, epidemiological cut-off value; MIC, minimum inhibitory
concentration.
Table 2. Streptomycin Resistance Genes in Escherichia
coli Strains with Minimum Inhibitory Concentration
Values Ranging From 4 to 32 mg/L
MIC (mg/L)
Genes 4 8 16 32
aadA 3 5 21 22
strB 0 4 3 1
strAþstrB 0 0 1 13
aadAþstrB 0 0 1 4
aadAþstrAþstrB 0 0 1 3
None 52 42 24 8
Number of strains 55 51 51 51
The gray color represents MIC values above the ECOFF value
suggested by the authors.
ECOFF, epidemiological cut-off value; MIC, minimum inhibitory
concentration.
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as belonging to the WT population, even though they har-
bored streptomycin resistance genes.
According to results obtained in this study, the aadA gene
appeared to be the most common streptomycin resistance
gene for both Salmonella and E. coli exhibiting MICs between
4 and 32mg/L. This is perhaps not surprising as previous
studies have suggested that the aadA genes can be involved
in conferring low-level resistance to streptomycin.20,21 It has
been shown that E. coli strains with an aadA cassette as the
second cassette within the variable region of integrons had
MICs of 4 and 8mg/L.20 Studies from the United States have
also described aadA cassettes within integrons in strepto-
mycin-susceptible Salmonella and E. coli.25,26 In addition, if
the aadA gene cassette is positioned in a class 1 integron, the
expression level may be influenced by the proximity of the
promoter. The MIC can also be influenced by copy number
of the gene cassette and also the potency of the promoter and
the presence or absence of a second promoter.4,11 In addition,
the serovar distribution in the Salmonella sample may dras-
tically influence the relative frequencies of the genes under
investigation.
The presence of both strA and strB was observed in a
number of strains, especially in E. coli. However, in this study
no apparent correlation was observed between the MIC value
and presence of a specific gene or gene combination. Still, a
high proportion of the strains did not test positive for any of
the three genes. However, other mechanisms of resistance,
such as mutations in the rpsL gene encoding the ribosomal
protein, S12 are also known to confer resistance to strepto-
mycin.7,22,24 Studies in our laboratories (National Food In-
stitute, Denmark) performed in a selection of E. coli and
Salmonella strains have not detected any mutations in the
isolates (data not shown). It is possible that other yet un-
known mechanisms mediating increased tolerance to strep-
tomycin are present in the strains without any known
streptomycin resistance genes, especially the strains with
MICs between 16 and 32mg/L. Hence, there are some limi-
tations with the methods since resistance genes can be present
but may not be expressed, and expression of the genes may
also be driven by promoter strength and copy number.23
Further, the primers used in this study only amplified an in-
ternal part of the resistance genes. There is a general as-
sumption that the presence of amplicons implies the presence
of a functional gene, but this might not always be the case.
This study and previous investigations have now shown
that resistance genes can be present in strains with low
streptomycin MICs such 4, 8, and 16mg/L.5,20,21 For some
antimicrobial agents there is a clear separation between the
WT and non-WT population; this is probably not the case for
streptomycin. Based on these observations, it is possible that
the MIC distribution of the streptomycin WT population
overlaps with the distribution of the non-WT population. If
this is the case, setting an ECOFF will be challenging and will
result in misclassification in either way. The fact that differ-
ent streptomycin resistance genes appear to be disseminated
and that various combinations of them can be present within
the same strain may also contribute to a wide variation of
MIC values, including those close to or within the predicted
WT population. The MIC span of 4 to 32mg/L may repre-
sent an interface area between the WT and non-WT popu-
lation for both E. coli and Salmonella.
To summarize, based on the streptomycin MIC distribution
for Salmonella and E. coli collected from 12 different countries
and comparison of them with the presence or absence of the
described genes, the authors of this study have agreed to rec-
ommend an ECOFF value of WT16mg/L for Salmonella and
WT8mg/L for E. coli. In this study the definition of these two
ECOFF values resulted in the misclassification of 11.3% of the
E. coli strains harboring resistance genes and exhibitingMICs 4
and 8mg/L and 5.5% of the Salmonella strains exhibiting MICs
4, 8, and 16mg/L. Taking into account that the reproducibility
of antimicrobial susceptibility methods performed in the same
strain could affect the MIC value obtained one fold dilution
either way, this percentage of misclassified organisms could
slightly vary. In addition, differences in the methods used for
antimicrobial susceptibility testing may also cause differences
in the results. In this study two of the laboratories performed
agar dilution methods and the rest used commercially avail-
able plateswith double dilutions of the antimicrobials on them.
However, in each laboratory, the same MIC method was used
for analyzing both Salmonella and E. coli strains, indicating that
there are differences in the presence of streptomycin resistance


















































FIG. 1. Distribution of the streptomycin MIC for Salmonella
and Escherichia coli from the different countries. The Salmo-
nella distribution was based on a total of 9,191 observations
from 11 different data sources, whereas the E. coli is based on
5,171 from 10 different data sources. MIC, minimum inhib-
itory concentration.
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The results from this survey emphasize the complexity of
establishing a clear ECOFF value for streptomycin due to a
large proportion of strains exhibiting high MIC values de-
spite the lack of a known mechanism of resistance, and the
fact that strains with low MICs can contain resistance genes.
Further work should be undertaken to reveal novel mecha-
nisms conferring resistance to aminoglycosides.
The establishment of a common ECOFF based on the
evaluation of both MIC distribution of the population
and characterization of resistance genes is vital to facilitate
a global harmonization of surveillance programs. For mon-
itoring programs the defined ECOFF should minimize the
misclassification of organisms harboring resistance genes
into the WT population and vice verse.
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